MyFinsight
Home
Blog
About
Marketable securities
$125,428K
(164.26%↑ Y/Y)
Cash and cash
equivalents
$26,329K
(2.24%↑ Y/Y)
Prepaid expenses and
other current assets
$3,141K
(-14.18%↓ Y/Y)
Total current assets
$154,898K
(101.49%↑ Y/Y)
Right-of-use asset
$26,389K
(-5.52%↓ Y/Y)
Property and equipment,
net
$4,397K
(-26.18%↓ Y/Y)
Restricted cash
$3,405K
(-15.80%↓ Y/Y)
Prepaid expenses and
other non-current...
$274K
Total assets
$189,363K
(64.78%↑ Y/Y)
Total liabilities and
stockholders equity
$189,363K
(64.78%↑ Y/Y)
Total stockholders
equity
$133,733K
(76.34%↑ Y/Y)
Total liabilities
$55,630K
(42.35%↑ Y/Y)
Accumulated deficit
-$707,367K
(-9.35%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$227K
(-22600.00%↓ Y/Y)
Additional paid-in capital
$841,319K
(16.41%↑ Y/Y)
Total current
liabilities
$38,042K
(81.95%↑ Y/Y)
Operating lease liability
$14,871K
(-2.20%↓ Y/Y)
Other liabilities
$2,717K
(-8.40%↓ Y/Y)
Common stock-Voting
Common Stock
$7K
(75.00%↑ Y/Y)
Common
stock-Nonvoting Common Stock
$1K
(0.00%↑ Y/Y)
Deferred revenue
$25,248K
Accrued expenses and
other current...
$7,983K
(-39.68%↓ Y/Y)
Operating lease liability
$2,779K
(2.51%↑ Y/Y)
Accounts payable
$2,032K
(-59.05%↓ Y/Y)
Back
Back
Balance Sheet
Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc (PRLD)
source: myfinsight.com